GSK Subsidiary TESARO Dismisses AnaptysBio's Anticipatory Breach Claim

GSK plc (GSK) subsidiary TESARO has had a motion to dismiss AnaptysBio's (ANAB) claim of anticipatory breach of contract granted by the Delaware Court of Chancery. The ruling does not address the underlying contractual dispute between the parties. The decision may have implications for ongoing legal and business relations between the companies.

By Arundhati Sarkar, SA News Editor · Seeking Alpha ·

GSK Subsidiary TESARO Dismisses AnaptysBio's Anticipatory Breach Claim

Tickers: $ANAB $GSK

Topics: contract breach court ruling legal dispute pharmaceutical industry

Read the full article at Seeking Alpha

More World news